0
There are 0 item in your cart
Cart Subtotal $0.00 Checkout
>   Home   >   Products   >      >   Viral Antigens   >   Norovirus Group-2   

Norovirus Group-2

Norovirus Group-2 Capsid Recombinant

 
Catalog #
VAG0406
Uniprot Id
B5AHE9
 
Be the first to write a review
 
 Catalog #AvailabilitySizeQuantityUnit Price Save For Later Wish List
VAG0406-100 7 days 100 µg $330.00
Select product before adding to cart
VAG0406-500 7 days 500 µg $1,320.00
VAG0406-1 7 days 1 mg $2,160.00
  • Datasheet
  • Citations
  • Reviews

Product Overview

NameNorovirus Group-2
Description
Norovirus Group-2 Capsid Recombinant
Accession (Primary)B5AHE9
Introduction
Human norovirus is classified into two groups, group 1& group 2. Norwalk virus is the species which belongs to group 1 and was discovered in 1968 at Ohio. Norovirus is a familiar virus which causes human gastroenteritis with the following symptoms vomiting, diarrhea and sickness. CDC report revealed that there are 19-21 million Americans infected by Nororvirus annually with 800 deaths, 1 in 15 people with infection. Around the world, this virus affects about 267 million people and causes over 200,000 deaths each year; these losses are mostly in less developed countries and in the very young, elderly and immuno-suppressed population, though, most cases are self-limited with a full recovery within just a few days. Norovirus is extremely contagious and can spread from human to human through infected food, water or contaminated surfaces. The outbreaks usually occur from November-April, while the peak is in January. Norovirus is a positive sense RNA virus with 7.5 kb nucleotides, encoding a major structural protein VP1 with 50-55kDa. The full length of VP1 capsid comprises the internal N-terminal, Hinge, shell (S) and protruding (P) domains. P domain from 225 to 520 forms P1- P2-P1 structure. Moreover, P domain has a receptor binding region which recognizes human histo-blood group antigens (HBGAs). P domain expressed in bacteria can spontaneously form a P dime as well as a P particle aggregated by 12 P dimmers. P particle displays an increased binding activity to HBGAs higher than virus-like particle (VLP) formed by the full-length capsid. For norovirus vaccine development, we consider P domain as a good candidate.
Source
Escherichia Coli.
Physical Appearance
Sterile Filtered clear solution.
Formulation
Phosphate buffer and 17mM K2CO3.
Stability
The Recombinant Norovirus Group-2 P-Domain although stable at 4°C for 1 week, should be stored below -18°C. Please prevent freeze thaw cycles .
Purity
Protein is >95% pure as determined by 12% PAGE (coomassie staining).
Precautions
Norovirus Group-2 is for research use only and not for use in diagnostic or therapeutic procedures.

Target Information: ( B5AHE9 )

Citation banner

Thousands of laboratories across the world have published research that depended on the performance of antibodies from ADMEbio to advance their research.
Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.

Thank you,
ADMEbio Team

Citation banner
Be the first to review product

ADMEbio welcomes feedback from our customers.

  • Be seen as an expert in the field of the products you are reviewing
  • Showcase your results (you can upload an image) to the antibody community. New product applications are welcome!
  • Share your experience to help other researchers make more informed decisions.
  • Easy process through our 5 star rating system and single login through your account.

Thank you,
ADMEbio Team






Order Information
Call
760-390-3989
Shipping Information
For shipping outside United State, please contact
sales@admebio.com